Thank you to the talented team @versanisbio for your commitment to advancing transformational treatments for so many people living with obesity and cardiometabolic disease. We are proud to be one of this year’s #Endpoints11!
Congrats to Versanis Bio. Over the past 20 years, CEO Mark Pruzanski has seen all the good times and all the bad times Nasdaq has had to offer biotech execs. He learned early that it takes tenacity to make it in biotech.
endpts.com/the-endpoints-11-…
Proud to lead the @VersanisBio team as we pioneer transformational treatments for people living with obesity and cardiometabolic disease. We’re honored to be one of this year’s #Endpoints11 most promising biotech startups!
This Post is from an account that no longer exists. Learn more
I am thrilled to have joined @VersanisBio to help pioneer transformational treatments for obesity and other cardiometabolic diseases!
This Post is from an account that no longer exists. Learn more